236 related articles for article (PubMed ID: 28211348)
1. Psoriatic Erythroderma Caused by Terbinafine: A Possible Pathogenetic Role for IL-23.
Oda T; Sawada Y; Yamaguchi T; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Okada E; Nakamura M
J Investig Allergol Clin Immunol; 2017; 27(1):63-64. PubMed ID: 28211348
[No Abstract] [Full Text] [Related]
2. Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature.
Gupta AK; Lynde CW; Lauzon GJ; Mehlmauer MA; Braddock SW; Miller CA; Del Rosso JQ; Shear NH
Br J Dermatol; 1998 Mar; 138(3):529-32. PubMed ID: 9580815
[TBL] [Abstract][Full Text] [Related]
3. [Oral terbinafine-induced plantar pustular psoriasis].
Le Guyadec T; Saint-Blancard P; Bosonnet S; Le Vagueresse R; Lanternier G
Ann Dermatol Venereol; 2000 Mar; 127(3):279-81. PubMed ID: 10804301
[TBL] [Abstract][Full Text] [Related]
4. Pustular psoriasis induced by terbinafine : differential diagnosis from acute generalized exanthematous pustulosis.
Tokuyama Y; Senoh A; Setsu N; Iwatsuki K
Eur J Dermatol; 2008; 18(6):725-6. PubMed ID: 19049946
[No Abstract] [Full Text] [Related]
5. [Terbinafine : Drug-induced lupus erythematodes and triggering of psoriatic skin lesions].
Mayser P
Hautarzt; 2016 Sep; 67(9):724-31. PubMed ID: 27455869
[TBL] [Abstract][Full Text] [Related]
6. Pustular psoriasiform eruption with leukocytosis associated with terbinafine.
Papa CA; Miller OF
J Am Acad Dermatol; 1998 Jul; 39(1):115-7. PubMed ID: 9674406
[No Abstract] [Full Text] [Related]
7. Generalized fixed drug eruption caused by pazufloxacin.
Sawada Y; Nakamura M; Tokura Y
Acta Derm Venereol; 2011 Sep; 91(5):600-1. PubMed ID: 21597677
[No Abstract] [Full Text] [Related]
8. Severe pustular psoriasis provoked by oral terbinafine.
Wilson NJ; Evans S
Br J Dermatol; 1998 Jul; 139(1):168. PubMed ID: 9764183
[No Abstract] [Full Text] [Related]
9. Clinical Efficiency of Topical Calcipotriol/Betamethasone Treatment in Psoriasis Relies on Suppression of the Inflammatory TNFα - IL-23 - IL-17 Axis.
Kubin ME; Kokkonen N; Palatsi R; Hägg PM; Väyrynen JP; Glumoff V; Haapasaari KM; Hurskainen T; Tasanen K
Acta Derm Venereol; 2017 Apr; 97(4):449-455. PubMed ID: 27868150
[TBL] [Abstract][Full Text] [Related]
10. Acute Generalized Exanthematous Pustulosis Caused by Faropenem: A Possible Pathogenetic Role for Interleukin-23.
Sakuragi Y; Sawada Y; Hara Y; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Nakamura M
Acta Derm Venereol; 2016 Feb; 96(2):265-6. PubMed ID: 26302837
[No Abstract] [Full Text] [Related]
11. Terbinafine therapy may be associated with the development of psoriasis de novo or its exacerbation: four case reports and a review of drug-induced psoriasis.
Gupta AK; Sibbald RG; Knowles SR; Lynde CW; Shear NH
J Am Acad Dermatol; 1997 May; 36(5 Pt 2):858-62. PubMed ID: 9146568
[TBL] [Abstract][Full Text] [Related]
12. A Case of Ixekizumab-induced Psoriasiform Eruption.
Oiwa T; Fujita M; Takase S; Nishimura Y; Ota M; Okada K; Tachibana T
Acta Derm Venereol; 2019 Apr; 99(4):446-447. PubMed ID: 30723870
[No Abstract] [Full Text] [Related]
13. Terbinafine-induced lichenoid drug eruption.
Zheng Y; Zhang J; Chen H; Lai W; Maibach HI
Cutan Ocul Toxicol; 2017 Mar; 36(1):101-103. PubMed ID: 26938740
[TBL] [Abstract][Full Text] [Related]
14. A diagnostic challenge: acute generalized exanthematous pustulosis or pustular psoriasis due to terbinafine.
Duckworth L; Maheshwari MB; Thomson MA
Clin Exp Dermatol; 2012 Jan; 37(1):24-7. PubMed ID: 21790726
[TBL] [Abstract][Full Text] [Related]
15. Severe erythema anulare centrifugum-like psoriatic drug eruption induced by terbinafine.
Wach F; Stolz W; Hein R; Landthaler M
Arch Dermatol; 1995 Aug; 131(8):960-1. PubMed ID: 7632075
[No Abstract] [Full Text] [Related]
16. Erythrodermic psoriasis and secukinumab: Our clinical experience.
Mateu-Puchades A; Santos-Alarcón S; Martorell-Calatayud A; Pujol-Marco C; Sánchez-Carazo JL
Dermatol Ther; 2018 Jul; 31(4):e12607. PubMed ID: 29663615
[No Abstract] [Full Text] [Related]
17. Generalized pustular psoriasis and hepatic dysfunction associated with oral terbinafine therapy.
Kim BS; Jang HS; Jwa SW; Jang BS; Kim MB; Oh CK; Kwon YW; Kwon KS
J Korean Med Sci; 2007 Feb; 22(1):167-9. PubMed ID: 17297275
[TBL] [Abstract][Full Text] [Related]
18. [Unusual side effects in patients with psoriatic erythroderma treated with etretinate (RO 10-9359)].
Castel T; Castro J; Lecha M; Mascaró JM
Med Cutan Ibero Lat Am; 1986; 14(2):83-6. PubMed ID: 2943953
[TBL] [Abstract][Full Text] [Related]
19. Drug Eruption Caused by Rosuvastatin.
Oda T; Sawada Y; Yamaguchi T; Ohmori S; Haruyama S; Yoshioka M; Okada E; Nakamura M
J Investig Allergol Clin Immunol; 2017; 27(2):140-141. PubMed ID: 28398205
[No Abstract] [Full Text] [Related]
20. Subacute lupus erythematosus-like eruption due to terbinafine: report of three cases.
Hill VA; Chow J; Cowley N; Marsden RA
Br J Dermatol; 2003 May; 148(5):1056. PubMed ID: 12786843
[No Abstract] [Full Text] [Related]
[Next] [New Search]
